112 related articles for article (PubMed ID: 7896748)
21. Binding kinetics of thrombin and antithrombin III with immobilized heparin using a spacer.
Byun Y; Jacobs HA; Kim SW
ASAIO J; 1992; 38(3):M649-53. PubMed ID: 1457941
[TBL] [Abstract][Full Text] [Related]
22. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine.
Gandrille S; Aiach M; Lane DA; Vidaud D; Molho-Sabatier P; Caso R; de Moerloose P; Fiessinger JN; Clauser E
J Biol Chem; 1990 Nov; 265(31):18997-9001. PubMed ID: 2229057
[TBL] [Abstract][Full Text] [Related]
23. Ability of high-affinity heparin fractions with decreasing affinity for antithrombin III to activate ATIII isoforms.
Carlson TH; Kolman MR; Frees A; Babcock T
Thromb Res; 1990 Aug; 59(3):521-30. PubMed ID: 2237824
[TBL] [Abstract][Full Text] [Related]
24. Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources.
Loganathan D; Wang HM; Mallis LM; Linhardt RJ
Biochemistry; 1990 May; 29(18):4362-8. PubMed ID: 2350542
[TBL] [Abstract][Full Text] [Related]
25. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
Schoen P; Wielders S; Petitou M; Lindhout T
Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
[TBL] [Abstract][Full Text] [Related]
26. Expression and characterization of recombinant human antithrombin III in Pichia pastoris.
Mochizuki S; Hamato N; Hirose M; Miyano K; Ohtani W; Kameyama S; Kuwae S; Tokuyama T; Ohi H
Protein Expr Purif; 2001 Oct; 23(1):55-65. PubMed ID: 11570846
[TBL] [Abstract][Full Text] [Related]
27. The interactions between antithrombin III, thrombin and surface immobilized heparin.
van Delden CJ; Engbers GH; Feijen J
J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
[TBL] [Abstract][Full Text] [Related]
28. Mapping and quantification of the major oligosaccharide components of heparin.
Linhardt RJ; Rice KG; Kim YS; Lohse DL; Wang HM; Loganathan D
Biochem J; 1988 Sep; 254(3):781-7. PubMed ID: 3196292
[TBL] [Abstract][Full Text] [Related]
29. Probing the heparin-binding domain of human antithrombin III with V8 protease.
Liu CS; Chang JY
Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis.
Zhang M; Li G; Zhang Y; Kang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():78-83. PubMed ID: 29031112
[TBL] [Abstract][Full Text] [Related]
31. Interaction of antithrombin III with surface-immobilized albumin-heparin conjugates.
van Delden CJ; Engbers GH; Feijen J
J Biomed Mater Res; 1995 Nov; 29(11):1317-29. PubMed ID: 8582900
[TBL] [Abstract][Full Text] [Related]
32. Thermodynamic analysis of heparin binding to human antithrombin.
DeLauder S; Schwarz FP; Williams JC; Atha DH
Biochim Biophys Acta; 1992 Sep; 1159(2):141-9. PubMed ID: 1390919
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial effects of helix D-derived peptides of human antithrombin III.
Papareddy P; Kalle M; Bhongir RK; Mörgelin M; Malmsten M; Schmidtchen A
J Biol Chem; 2014 Oct; 289(43):29790-800. PubMed ID: 25202017
[TBL] [Abstract][Full Text] [Related]
34. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.
Bock SC; Marrinan JA; Radziejewska E
Biochemistry; 1988 Aug; 27(16):6171-8. PubMed ID: 3191114
[TBL] [Abstract][Full Text] [Related]
35. Investigating changes in the gas-phase conformation of Antithrombin III upon binding of Arixtra using traveling wave ion mobility spectrometry (TWIMS).
Zhao Y; Singh A; Li L; Linhardt RJ; Xu Y; Liu J; Woods RJ; Amster IJ
Analyst; 2015 Oct; 140(20):6980-9. PubMed ID: 26115461
[TBL] [Abstract][Full Text] [Related]
36. Lysine residue 114 in human antithrombin III is required for heparin pentasaccharide-mediated activation.
Kridel SJ; Knauer DJ
J Biol Chem; 1997 Mar; 272(12):7656-60. PubMed ID: 9065421
[TBL] [Abstract][Full Text] [Related]
37. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
Byun Y; Jacobs HA; Kim SW
Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
[TBL] [Abstract][Full Text] [Related]
38. Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III.
Baruch D; Ajzenberg N; Denis C; Legendre P; Lormeau JC; Meyer D
Thromb Haemost; 1994 Jan; 71(1):141-6. PubMed ID: 8165633
[TBL] [Abstract][Full Text] [Related]
39. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
[TBL] [Abstract][Full Text] [Related]
40. Antithrombin III and its interaction with heparin. Comparison of the human, bovine, and porcine proteins by 1H NMR spectroscopy.
Gettins P
Biochemistry; 1987 Mar; 26(5):1391-8. PubMed ID: 3567176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
